Is endocan a biochemical marker for asymptomatic target organ damage in hypertensive patients?

Identification of the asymptomatic target organ damage (AOD) helps to stratify the overall risk of cardiovascular (CV) diseases and guides a treatment decision in hypertensive patients without a symptomatic CV or renal disease. The endothelial-cell-specific molecule 1 (endocan) is regarded as a nove...

Ausführliche Beschreibung